share_log

Cyclacel Pharmaceuticals Inc | 4: Statement of changes in beneficial ownership of securities-Director Ferguson Kenneth M.

Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | 4:持股变动声明-董事 Ferguson Kenneth M.

美股SEC公告 ·  2023/07/03 16:56
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息